Deerfield Management Co /ny
10% owner at QTTB; 10% owner at ACRS; 10% owner at XERIS PHARMACEUTICALS INC, and 16 more
- Sold, on record
- $31.6M
- Dollars the filings state
- Form 4 sales
- 28
- Latest Dec 24, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 19
- Filed as an executive or holder
Companies
- QTTBQ32 Bio Inc.10% owner
- ACRSAclaris Therapeutics, Inc.10% owner
- XERIS PHARMACEUTICALS INC10% owner
- AVDLAVADEL PHARMACEUTICALS PLC10% owner
- GYREGYRE THERAPEUTICS, INC.10% owner
- TARAProtara Therapeutics, Inc.Director
- CAS MEDICAL SYSTEMS INC10% owner
- LRMRLarimar Therapeutics, Inc.10% owner
- EHTHeHealth, Inc.10% owner
- STRMSTREAMLINE HEALTH SOLUTIONS INC.10% owner
- ANTARES PHARMA, INC.10% owner
- AXGNAxogen, Inc.10% owner
- Hana Biosciences Inc10% owner
- NeuroMetrix, Inc.10% owner
- NeurogesX Inc10% owner
- DUSA PHARMACEUTICALS INC10% owner
- BGMSBio Green Med Solution, Inc.10% owner
- VIA Pharmaceuticals, Inc.10% owner
- THIRD WAVE TECHNOLOGIES INC /WI10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- NeuroMetrix, Inc.2.2M shares
- ANTARES PHARMA, INC.1.5M shares
- LRMR1.3M shares
- Hana Biosciences Inc1.2M shares
- ACRS699,475 shares
- BGMS443,257 shares
- STRM397,259 shares
- QTTB350,000 shares
- EHTH312,089 shares
- NeurogesX Inc275,313 shares
- CAS MEDICAL SYSTEMS INC205,126 shares
- AXGN144,385 shares
- AVDL114,034 shares
- TARA110,557 shares
- VIA Pharmaceuticals, Inc.85,703 shares
- GYRE71,778 shares
- THIRD WAVE TECHNOLOGIES INC /WI69,411 shares
- DUSA PHARMACEUTICALS INC29,848 shares
- XERIS PHARMACEUTICALS INC14,807 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale LRMRUnusualJul 20, 2016 2016
Sold 1.3M shares at $3.31 ($4.4M)
Deerfield Management Co, 10% owner
Sold 53.8% of holdings ($8.3M position)1.2M shares leftFirst sale on recordFiling
- 2 Form 4 sale CAS MEDICAL SYSTEMS INCPlan not statedJan 23, 2017 +187 days
Sold 205,126 shares at $1.53 ($314k)
Deerfield Management Co, 10% owner
Sold 6.4% of holdings ($4.9M position)3M shares leftFirst sale on recordFiling
- 3 Form 4 sale TARAUnusualNov 30, 2017 +311 days
Sold 110,557 shares at $1.75 ($193k)
Deerfield Management Co, Director
Sold 100% of holdings ($193k position)0 shares leftFirst sale on recordFiling
- 4 Form 4 sale GYREPlan not statedMar 8, 2018 +98 days
Sold 71,778 shares at $30.53 ($2.2M)
Deerfield Management Company, L.P. (series C), 10% owner
Sold 6.1% of holdings ($36.2M position)1.1M shares leftFirst sale on recordFiling
- 5 Form 4 sale AVDLPlan not statedJun 25, 2018 +109 days
Sold 114,034 shares at $5.99 ($683k)
Deerfield Management Company, L.P. (series C), 10% owner
Sold 10.7% of holdings ($6.4M position)952,265 shares leftFirst sale on recordFiling
- 6 Form 4 sale XERIS PHARMACEUTICALS INCPlan not statedFeb 7, 2019 +227 days
Sold 14,807 shares at $15.02 ($222k)
Deerfield Management Company, L.P. (series C), 10% owner
Sold 1.7% of holdings ($13.2M position)863,711 shares leftFirst sale on recordFiling
- 7 Form 4 sale ACRSPlan not statedJun 27, 2019 +140 days
Sold 699,475 shares at $2.69 ($1.9M)
Deerfield Management Company, L.P. (series C), 10% owner
Sold 18.1% of holdings ($10.4M position)3.2M shares leftFirst sale on recordFiling
- 8 Form 4 sale QTTBPlan not statedDec 24, 2019 +180 days
Sold 350,000 shares at $21.95 ($7.7M)
Deerfield Management Company, L.P. (series C), 10% owner
Sold 16.5% of holdings ($46.4M position)1.8M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (28)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 24, 2019 | Dec 27, 2019 | QTTB | 10% owner | Form 4 sale | 350,000 | $7.7M | 16.5% | Plan not stated | SEC |
| Jun 27, 2019 | Jul 1, 2019 | ACRS | 10% owner | Form 4 sale | 699,475 | $1.9M | 18.1% | Plan not stated | SEC |
| Feb 7, 2019 | Feb 7, 2019 | XERIS PHARMACEUTICALS INC | 10% owner | Form 4 sale | 14,807 | $222k | 1.7% | Plan not stated | SEC |
| Jun 25, 2018 | Jun 25, 2018 | AVDL | 10% owner | Form 4 sale | 114,034 | $683k | 10.7% | Plan not stated | SEC |
| Mar 8, 2018 | Mar 8, 2018 | GYRE | 10% owner | Form 4 sale | 71,778 | $2.2M | 6.1% | Plan not stated | SEC |
| Nov 30, 2017 | Dec 4, 2017 | TARA | Director | Form 4 sale | 110,557 | $193k | 100.0% | Unusual | SEC |
| Jan 23, 2017 | Jan 23, 2017 | CAS MEDICAL SYSTEMS INC | 10% owner | Form 4 sale | 205,126 | $314k | 6.4% | Plan not stated | SEC |
| Jul 20, 2016 | Aug 1, 2016 | LRMR | 10% owner | Form 4 sale | 1.3M | $4.4M | 53.8% | Unusual | SEC |
| Jun 2, 2016 | Jun 2, 2016 | EHTH | 10% owner | Form 4 sale | 99,508 | $1.4M | 8.8% | Plan not stated | SEC |
| May 27, 2016 | May 27, 2016 | EHTH | 10% owner | Form 4 sale | 212,581 | $3M | 15.8% | Plan not stated | SEC |
| Dec 17, 2015 | Dec 17, 2015 | STRM | 10% owner | Form 4 sale | 397,259 | $488k | 17.5% | Plan not stated | SEC |
| Jul 1, 2015 | Jul 1, 2015 | ANTARES PHARMA, INC. | 10% owner | Form 4 sale | 713,222 | $1.5M | 9.8% | Plan not stated | SEC |
| Jun 15, 2015 | Jun 15, 2015 | ANTARES PHARMA, INC. | 10% owner | Form 4 sale | 748,030 | $1.8M | 16.5% | Plan not stated | SEC |
| Apr 8, 2015 | Apr 9, 2015 | AXGN | 10% owner | Form 4 sale | 144,385 | $469k | 3.7% | Plan not stated | SEC |
| Jul 5, 2012 | Jul 9, 2012 | Hana Biosciences Inc | 10% owner | Form 4 sale | 540,000 | $659k | 79.8% | Unusual | SEC |
| Jun 28, 2012 | Jun 28, 2012 | Hana Biosciences Inc | 10% owner | Form 4 sale | 398,373 | $413k | 34.7% | Unusual | SEC |
| Jun 27, 2011 | Jun 27, 2011 | Hana Biosciences Inc | 10% owner | Form 4 sale | 245,500 | $254k | 15.7% | Plan not stated | SEC |
| Jun 13, 2011 | Jun 15, 2011 | Hana Biosciences Inc | 10% owner | Form 4 sale | 33,181 | $34k | 2.3% | Plan not stated | SEC |
| Dec 14, 2010 | Dec 14, 2010 | NeuroMetrix, Inc. | 10% owner | Form 4 sale | 331,900 | $169k | 29.8% | Unusual | SEC |
| Nov 18, 2010 | Nov 18, 2010 | NeuroMetrix, Inc. | 10% owner | Form 4 sale | 902,647 | $525k | 47.6% | Unusual | SEC |
| Aug 19, 2010 | Aug 23, 2010 | NeuroMetrix, Inc. | 10% owner | Form 4 sale | 1M | $785k | 31.6% | Unusual | SEC |
| Jun 30, 2009 | Jul 1, 2009 | NeurogesX Inc | 10% owner | Form 4 sale | 275,313 | $1.6M | 18.6% | Plan not stated | SEC |
| Feb 24, 2009 | Feb 25, 2009 | DUSA PHARMACEUTICALS INC | 10% owner | Form 4 sale | 29,848 | $32k | 1.9% | Plan not stated | SEC |
| Nov 19, 2008 | Nov 20, 2008 | BGMS | 10% owner | Form 4 sale | 443,257 | $121k | 33.5% | Unusual | SEC |
| Nov 6, 2007 | Nov 7, 2007 | VIA Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 63,238 | $203k | 4.8% | Plan not stated | SEC |
| Oct 25, 2007 | Oct 26, 2007 | VIA Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 16,120 | $63k | 1.2% | Plan not stated | SEC |
| Oct 18, 2007 | Oct 19, 2007 | VIA Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 6,345 | $26k | 0.5% | Plan not stated | SEC |
| Apr 27, 2007 | Apr 27, 2007 | THIRD WAVE TECHNOLOGIES INC /WI | 10% owner | Form 4 sale | 69,411 | $393k | 6.8% | Plan not stated | SEC |